RAHF PFM ALPHANINE SD COAGULATION FACTOR IX J7193 COAGULATION FACTOR IX (RFIXFC)

Similar documents
MDwise Self-Administered Codes for Medical

Aetna Better Health. Specialty Drug Program

Descriptor Brand Name. Alprostadil, Caverject, Edex, Prostin VR Pediatric. Calcimar, Miacalcin

Medication Prior Authorization Form

SELF-ADMINISTERED MEDICATIONS LIST

Exclusion Reasons Presumption of Long- Term Non-Acute Administration C9399 Unclassified Drugs or

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION

Quarterly Pharmacy Formulary Change Notice

Prior Authorization Program

Thank you for your request for information that has been processed under reference number

Cigna Drug and Biologic Coverage Policy

List of Designated High-Cost Drugs

J-Code Trade Name Drug Name Required Medical Information

MedStar Medicare Choice Pharmacy Services

Medication Prior Authorization Form

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION

Pharmacy Services Request Types

1199SEIU Benefit Funds

FIDELIS CARE NEW YORK DEPARTMENT OF PHARMACY SERVICES J Code Prior Authorizations & Required Clinical Information 2011 (Updated 3/14/11)

Method of Viral Inactivation or Depletion. Generation/ Human or Animal Protein in Culture. Third/ None 1. Immunoaffinity

Drug Name Generic Name J-Code Unclassified Drugs in excess of $10,000

2010 Drugs Requiring Prior Authorization

SPECIALTY PHARMACY Master Clinical Drug List

BCBS AZ ADV PLUS * CLASSIC * PREMIER For use with members associated with the BHN Network Prior Authorization List 2015

Medi-Cal DHCS Carve Out Medication List

Utilization Management

Immune Modulating Drugs Prior Authorization Request Form

Advantage by Peach State Health Plan 2012 Prior Authorization Listing. Approved 10/23/2011 Effective October 2011

METABOLIC, IMMUNE DISORDERS OR INHERITED RARE DISEASE ALPHA-1 PROTEINASE INHIBITORS ARANESP BLOOD CELL DEFICIENCY ARANESP ARCALYST

Self-Injected Medications and Disposal Recommendations

Formulary Changes. One mission: you TABLE A. FORMULARY CHANGES 7/1/2018: Commercial 3-Tier Formulary. Commercial 4-Tier Formulary

Positively Affecting the Lives of Members Each and Every Day. Volume 14 May Specialty Drug News

Specialty conditions overview

1199SEIU Benefit Funds

Original Policy Date

1199SEIU Benefit Funds

Injections Requiring Prior Authorization

TRICARE Uniform Formulary. Pre-Authorization Requirements

Texas Prior Authorization Program Clinical Edit Criteria

Drug Name Tier Drug Name Tier

ACTEMRA (tocilizumab)

CIMZIA (certolizumab pegol)

Prescription Drug Benefit Rider V

of our members each and

LDI integrated pharmacy services

ACAMPROSATE (CAMPRAL)

Download full Test Bank for Focus on Nursing Pharmacology 6th Edition by Karch

1199SEIU Benefit Funds

Prescription Drug Benefit Rider

Injectable Drugs Requiring Pre-Service Approval

Drug Class Prior Authorization Criteria Therapeutic Agents in Rheumatic and Inflammatory Diseases

Percent Brand Name Generic Name Strength How Supplied NDC from AWP/SWP Adcetris. Amprya dalfampridine 10 mg 60 count bottle

Xeljanz. Xeljanz, Xeljanz XR (tofacitinib) Description

after reconstitution No Yes Refrigerate; do Not freeze. Discard unused portions; do Not save for further Immune Deficiencies & Related

Specialty Overview by Prior Authorization Approval or Denial 2nd Quarter 2016

Cosentyx. Cosentyx (secukinumab) Description

Quick Reference: Plasma Protein Products

Cimzia. Cimzia (certolizumab pegol) Description

ACTEMRA. Cigna Medicare Rx (PDP) 2014 Cigna Medicare Rx Secure-Xtra Plan (PDP) Formulary. Products Affected Actemra. Prior Authorization Criteria

Regulatory Status FDA-approved indication: Orencia is a selective T cell co-stimulation modulator indicated for: (1)

Client Prior Authorization Program (CPA) PA Required (PA) Reimb Code. Reimb Code CLAIM EDIT. Reimb Code. Reimb Code. Reimb Code

DME MAC Jurisdiction C Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2018 through 03/31/2018

DME MAC Jurisdiction B Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2019 through 03/31/2019

Funding Position of CCG Commissioned High Cost Drugs within Lancashire Health Economy Updated February 2016

Medicare Part B Covered Medications

Trusted Health Plan Formulary

Trusted Health Plan Formulary

The Effect of Current Managed Care Trends on Patient Access in 3 Specialty Classes MS, Hepatitis C & Pulmonary Arterial Hypertension

Prior January 2016 Authorization What Is Prior Authorization? What Happens at a Retail Pharmacy? Please Note: Which Medications Are Included?

Divya Jain Arwindekar, DO Transplant Nephrologist Advocate Christ Medical Center & Associates in Nephrology

J1556 INJECTION, IMMUNE GLOBULIN (BIVIGAM) 500 MG $ J1559 INJECTION, IMMUNE GLOBULIN (HIZENTRA) 100 MG $14.364

2011 Medicare National Preferred 4 Tier PA Criteria

Specialty Pharmacy Pipeline

Prior Authorization April 2018

Specialty Overview by Prior Authorization Approval or Denial 4th Quarter 2016

Pharmacy Clinical Prior Authorization Assistance Chart Effective February 2018

2011 Medicare National Preferred 4 Tier PA Criteria

Drug Name. J0129 Injection, abatacept (Orencia ), 10 mg Effective 01/01/2014. J0178 Injection, aflibercept (Eylea ), 1 mg Effective 04/01/2015

Health Choice Generations HMO Medicare Advantage Special Needs Plan PRIOR AUTHORIZATION GUIDELINES

Section I contains changes to the Highmark Select/Choice Formulary.

Specialty Drugs. The following is a list of medications that are considered to be specialty drugs. Specialty drugs

ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018

2018 BCN Advantage Prior Authorization Criteria Last updated: November, 2017

LIMITED DISTRIBUTION MEDICATIONS

2018 BCN Advantage Prior Authorization Criteria Last updated: April, 2018

SUPPLEMENTARY INFORMATION

2011 RxBlue PDP PA Criteria

Medication Policy Manual. Topic: Otezla, apremilast Date of Origin: May 9, 2014

Medication Policy Manual. Topic: Xeljanz, tofacitinib Date of Origin: January 21, 2013

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Otezla. Otezla (apremilast) Description

Brand Generic J-Code 1 Billable. Exclusion Criteria. Information and Criteria. Unit

Prior Authorization Medications Requiring Review Criteria for Use

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

Coding Implications Revision Log. See Important Reminder at the end of this policy for important regulatory and legal information.

2018 Medicaid Preapproval Criteria

Prior Authorization Medications Requiring Review Criteria for Use

(Last Revised 10/04/18)

Transcription:

INFECTIOUS DISEASE ACTIMMUNE INTERFERON GAMMA 1B J9216 ADVATE RAHF PFM ONCOLOGY ORAL AFINITOR EVEROLIMUS J7527 INFECTIOUS DISEASE ALFERON N INTERFERON ALFA N3 J9215 ALPHANATE VWF J7186 ALPHANINE SD J7193 ALPROLIX (RFIXFC) J7201 MOVEMENT APOKYN APOMORPHINE HCL J0364 CRYOPYRIN ASSOCIATED PERIODIC SYNDROMES ARCALYST RILONACEPT J2793 TRANSPLANT ASTAGRAF XL TACROLIMUS J7508 J7507 MULTIPLE SCLEROSIS AVONEX INTERFERON BETA 1A Q3027 BEBULIN FACTOR IX COMPLEX J7194 BENEFIX (RECOMB) J7195 MULTIPLE SCLEROSIS BETASERON INTERFERON BETA 1B J1830 CYSTIC FIBROSIS BETHKIS TOBRAMYCIN J7682 TRANSPLANT CELLCEPT MYCOPHENOLATE MOFETIL J7517 INFLAMMATORY BOWEL DISEASE CIMZIA CERTOLIZUMAB PEGOL J0717 J0718, C9249 RHEUMATOID ARTHRITIS CIMZIA CERTOLIZUMAB PEGOL J0717 J0718, C9249 MULTIPLE SCLEROSIS COPAXONE GLATIRAMER ACETATE J1595 FACTOR XIII CONCENTRATE CORIFACT HUMAN J7180

ELOCTATE RAHF PFM Q9975 PSORIASIS ENBREL ETANERCEPT J1438 RHEUMATOID ARTHRITIS ENBREL ETANERCEPT J1438 TRANSPLANT ENVARSUS XR TACROLIMUS J7508 EPOPROSTENOL SODIUM EPOPROSTENOL SODIUM J1325 S0155 MULTIPLE SCLEROSIS EXTAVIA INTERFERON BETA 1B J1830 FEIBA ANTIINHIBITOR COAGULANT CMPLX J7198 HEREDITARY ANGIOEDEMA FIRAZYR ICATIBANT ACETATE J1744 OSTEOPOROSIS FORTEO TERIPARATIDE J3110 HIV MEDICATIONS FUZEON ENFUVIRTIDE J1324 RELATED : GAMASTAN S/D IMMUNE GLOBULIN J1460 J1560, J1480, J1490, J1500, J1510, J1520, J1530, J1540, 90281 TRANSPLANT GENGRAF CYCLOSPORINE MODIFIED J7502 J7515, C9438 RELATED GENOTROPIN SOMATROPIN J2941 MULTIPLE SCLEROSIS GLATOPA GLATIRAMER ACETATE J1595 ONCOLOGY ORAL GLEEVEC IMATINIB MESYLATE S0088 TRANSPLANT HECORIA TACROLIMUS J7507 HELIXATE HEMOFIL M J7190

UNCLASSIFIED HEMOPHILIA RELATED : HEMOPHILIA CLOTTING FACTOR, NOT OTHERWISE CLASSIFIED HEPAGAM B HEMOPHILIA CLOTTING FACTOR, NOT OTHERWISE CLASSIFIED HEPATITIS B IMMUNE GLOBULIN J7199 J1573 HORMONAL THERAPIES HP ACTHAR GEL CORTICOTROPIN J0800 SEIZURE HP ACTHAR GEL CORTICOTROPIN J0800 RELATED INFLAMMATORY BOWEL DISEASE HUMATE P VWF J7187 HUMATROPE SOMATROPIN J2941 HUMIRA ADALIMUMAB J0135 PSORIASIS HUMIRA ADALIMUMAB J0135 RHEUMATOID ARTHRITIS HUMIRA ADALIMUMAB J0135 ONCOLOGY ORAL HYCAMTIN TOPOTECAN HCL J8705 RELATED : CRYOPYRIN ASSOCIATED PERIODIC SYNDROMES RELATED HYPERHEP B HEPATITIS B IMMUNE GLOBULIN 90371 ILARIS CANAKINUMAB J0638 INCRELEX MECASERMIN J2170 HEPATITIS C INFERGEN INTERFERON ALFACON 1 J9212 HEMOPHILIA IXINITY (RFIXFC) J7195 KOATE J7190 KOGENATE 90371, J1571 MONOCLATE J7190

MONONINE J7193 TRANSPLANT MYFORTIC MYCOPHENOLATE SODIUM J7518 RELATED : NABI HB/NP NABI HEPATITIS B IMMUNE HB GLOBULIN 90371 TRANSPLANT NEORAL CYCLOSPORINE MODIFIED J7502 J7515, C9438 RELATED NORDITROPIN SOMATROPIN J2941 NOVOEIGHT RPFVIII J7182 NOVOSEVEN RT COAGULATION FACTOR VIIA RECOMB J7189 IMMUNE (IDIOPATHIC) THROMBOCYTOPENIA PURPURA RELATED RELATED NPLATE ROMIPLOSTIM J2796 C9245 NUTROPIN SOMATROPIN J2941 NUWIQ OBIZUR RPFVIII RPFVIII OMNITROPE SOMATROPIN J2941 HEPATITIS C PEGASYS PEGINTERFERON ALFA 2A S0145 HEPATITIS C PEG INTRON PEGINTERFERON ALFA 2B S0148 PROFILNINE SD FACTOR IX COMPLEX J7194 TRANSPLANT PROGRAF TACROLIMUS J7507

CYSTIC FIBROSIS PULMOZYME DORNASE ALFA J7639 TRANSPLANT RAPAMUNE SIROLIMUS J7520 MULTIPLE SCLEROSIS REBIF INTERFERON BETA 1A Q3028 J1826, Q3026 RECOMBINATE REFACTO REMODULIN TREPROSTINIL SODIUM J3285 HIV MEDICATIONS RETROVIR ZIDOVUDINE S0104 REVATIO SILDENAFIL CITRATE S0090 RIASTAP RIXUBIS FIBRINOGEN CONCENTRATE (RECOMB) J7178 J7200 J7195, C9133 HEREDITARY ANGIOEDEMA RUCONEST C1 ESTERASE INHIBITOR (RECOMB) C9445 RELATED SAIZEN SOMATROPIN J2941 TRANSPLANT SANDIMMUNE CYCLOSPORINE J7502 J7515 RELATED SEROSTIM SOMATROPIN J2941 ACROMEGALY SOMATULINE LANREOTIDE ACETATE J1930 C9237 ONCOLOGY CHEMOTHERAPY SOMATULINE LANREOTIDE ACETATE J1930 C9237 PSORIASIS STELARA USTEKINUMAB J3357 C9261 HORMONAL THERAPIES SUPPRELIN HISTRELIN ACETATE (CPP) J9226 RESPIRATORY SYNCYTIAL VIRUS SYNAGIS PALIVIZUMAB 90378 C9003 ONCOLOGY ORAL TEMODAR TEMOZOLOMIDE J8700 RELATED TEV TROPIN SOMATROPIN J2941 CYSTIC FIBROSIS TOBI TOBRAMYCIN J7682

TRETTEN COAGULATION FACTOR XIII A SUB J7181 TYVASO TREPROSTINIL J7686 J7180 VELETRI EPOPROSTENOL SODIUM J1325 S0155 VENTAVIS ILOPROST Q4074 HIV MEDICATIONS VIDEX DIDANOSINE S0137 WILATE VWF J7183 C9267 ONCOLOGY ORAL XELODA CAPECITABINE J8520 J8521 DUPUYTREN'S COLLAGENASE CLOSTRID XIAFLEX CONTRACTURE HISTOLYT J0775 C9266 ALLERGIC ASTHMA XOLAIR OMALIZUMAB J2357 C9217 RELATED XYNTHA RECOMBINANT PAF J7185 ZORBTIVE SOMATROPIN J2941 TRANSPLANT ZORTRESS EVEROLIMUS J7527